Disclosures for "Clinical significance and limitations of Commercial Rat Brain Immunohistochemistry as a Screening Test for Neuronal Surface Antibodies")
-
The institution of Dr. Iizuka has received research support from Astellas Pharma Inc.
-
Dr. Nagata has nothing to disclose.
-
Naomi Kanazawa has nothing to disclose.
-
Dr. Iizuka has nothing to disclose.
-
Dr. Nagashima has nothing to disclose.
-
Masaaki Nakamura, 435 has nothing to disclose.
-
Juntaro Kaneko has nothing to disclose.
-
Eiji Kitamura, 589 has nothing to disclose.
-
Kazutoshi Nishiyama, MD, PhD has nothing to disclose.